Skip to content

Does topical pain relief before Intravenous line placement improve patient satisfaction ?

QI EMLA - QILA

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/03/023726
Enrollment
200
Registered
2020-03-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 2- Placement

Interventions

None listed

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: All elective IV cannulations in ER and operation theatre .Age: 1 to 15 Years

Exclusion criteria

Exclusion criteria: a.Critical/emergency cases b. Major neurological/developmental delay c. Parent not consenting d. Allergy to local anaesthetics e. Patients taking drugs associated with drug-induced methemoglobinemia such as sulfonamides, acetanilid, aniline dyes, benzocaine, chloroquine, dapsone, naphthalene, nitrates and nitrites, nitrofurantoin, nitroglycerin, nitroprusside, pamaquine, para-aminosalicylic acid, phenacetin, phenobarbital, phenytoin, primaquine, quinine

Design outcomes

Primary

MeasureTime frame
The main aim of the project is to determine whether implementation of painless Intravenous cannulation with the help of EMLA cream will reduce patient pain scores and improve parent satisfaction scores in paediatric age group in the Emergency Room (ER)Timepoint: Base Line data 15 days Training 15 days Assessment of interventions 3 months

Secondary

MeasureTime frame
To determine feasibility to achieve 100 % coverage and reduction of Visual Analogue scale (VAS) scores by 50 % when compared to pre-intervention data. This will be achieved by steady improvement in the numbers of patients undergoing pain-free Intravascular access up to 80 % of the total elective cannulations in the Emergency room. 3. To form a reference for feasibility study for the effective implementation of the same in a wider clientele after achieving an 80 % coverage in the ER Timepoint: 04 months

Countries

India

Contacts

Public ContactHARINDRA KUMAR GOJE

rainbow children s Hospital

msubrah@gmail.com9000033011

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026